bluebird bio
Stock Forecast, Prediction & Price Target
bluebird bio Financial Estimates
bluebird bio Revenue Estimates
bluebird bio EBITDA Estimates
bluebird bio Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $3.66M N/A | $3.59M -1.77% | $29.49M 720.04% | Avg: $261.96M Low: $217.88M High: $313.96M avg. 788.10% | Avg: $303.88M Low: $231.98M High: $395.93M avg. 16.00% | Avg: $387.01M Low: $295.44M High: $504.24M avg. 27.35% | Avg: $452.15M Low: $345.17M High: $589.11M avg. 16.83% |
Net Income
% change YoY
| $-562.63M N/A | $-266.57M 52.61% | $-211.91M 20.50% | Avg: $-174.21M Low: $-119.44M High: $3.92M avg. 17.78% | Avg: $-130.37M Low: $-44.00M High: $-38.50M avg. 25.16% | Avg: $-27.50M Low: $-38.33M High: $-19.04M avg. 78.90% | Avg: $-4.32M Low: $-6.02M High: $-2.99M avg. 84.28% |
EBITDA
% change YoY
| $-539.30M N/A | $-277.21M 48.59% | $-167.16M 39.69% | Avg: $-261.96M Low: $-313.96M High: $-217.88M avg. -56.71% | Avg: $-303.88M Low: $-395.93M High: $-231.98M avg. -16.00% | Avg: $-387.01M Low: $-504.24M High: $-295.44M avg. -27.35% | Avg: $-452.15M Low: $-589.11M High: $-345.17M avg. -16.83% |
EPS
% change YoY
| -$8.16 N/A | -$3.39 58.45% | -$1.93 43.06% | Avg: -$0.81 Low: -$1.52 High: $0.05 avg. 58.28% | Avg: -$0.53 Low: -$0.56 High: -$0.49 avg. 34.79% | Avg: -$0.35 Low: -$0.49 High: -$0.24 avg. 33.33% | Avg: -$0.06 Low: -$0.08 High: -$0.04 avg. 84.28% |
Operating Expenses
% change YoY
| $529.91M N/A | $275.67M -47.97% | $240.23M -12.85% | Avg: $5.54B Low: $4.61B High: $6.64B avg. 2207.58% | Avg: $6.43B Low: $4.90B High: $8.37B avg. 16.00% | Avg: $8.18B Low: $6.25B High: $10.67B avg. 27.35% | Avg: $9.56B Low: $7.30B High: $12.46B avg. 16.83% |
FAQ
What is bluebird bio stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 51.53% in 2025-2028.
We have gathered data from 8 analysts. Their low estimate is -119.44M, average is -174.21M and high is 3.92M.
What is bluebird bio stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 212.07% in 2025-2028.
We have gathered data from 8 analysts. Their low revenue estimate is $217.88M, average is $261.96M and high is $313.96M.
What is bluebird bio stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 52.67% in 2025-2028.
We have gathered data from 8 analysts. Their low earnings per share estimate is -$1.52, average is -$0.81 and high is $0.05.
What is the best performing analyst?
In the last twelve months analysts have been covering bluebird bio stock. The most successful analyst is Gena Wang whose win rate is 100%. He has correctly predicted 1/1 price targets.